Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Apr 19;17(4):e82556.
doi: 10.7759/cureus.82556. eCollection 2025 Apr.

Inflammatory Myofibroblastic Tumor of the Prostate Gland: A Case Report From North-Central Nigeria

Kevin N Ezike  1 , Ijeoma A Okwudire-Ejeh  2 , Bamnan C Dallang  1 , Emmanuel O Adugba  3 , Ugonna N Ezike  4
Affiliations
Case Reports

Inflammatory Myofibroblastic Tumor of the Prostate Gland: A Case Report From North-Central Nigeria

Kevin N Ezike et al. Cureus. .

Abstract

Inflammatory myofibroblastic tumors (IMTs) are mesenchyme-derived tumors of undetermined malignant potential, generally considered low-grade tumors. They occur within various organs, with the abdominal cavity as the most common site of occurrence. The male genitourinary system, especially the prostate gland, is among the least common sites of occurrence. IMTs are generally diagnosed in the young, where they present as circumscribed masses with symptoms referable to the location and size. Occasionally, however, they present in the elderly. The etiopathogenesis is postulated to be related to an abnormality in chromosome 2p23.5, and association with anaplastic lymphoma receptor tyrosine kinase (ALK) positivity on immunohistochemistry (IHC) has therapeutic and prognostic implications. Distinguishing IMTs from non-neoplastic mimics like inflammatory pseudotumor (IPT) is important because they have similar microscopic features, characterized by benign spindle and stellate cells of variable cellularity, admixed with mixed inflammatory cell infiltrates in a fibrocollagenous background. Surgery is the treatment of choice, with a favorable outcome in most cases. Targeted therapy with the tyrosine kinase inhibitor (TKI) crizotinib is increasingly touted in recurrent cases or those not amenable to surgery. We present a case of IMT in a 77-year-old Nigerian male who was clinically diagnosed as a case of benign prostatic hyperplasia (BPH), in order to highlight the imperative for a high index of suspicion in the histopathological evaluation of prostatic lesions.

Keywords: alk gene translocation; bladder outlet obstruction; inflammatory myofibroblastic tumor; nigeria; prostate gland.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Inflammatory myofibroblastic tumor of the prostate gland
(A) Note haphazard fascicles of spindled to stellate cells, exhibiting variable areas of hypo- and hypercellularity (blue and red arrows, respectively), set in vascularized fibrocollagenous stroma (H&E, x40). (B) Note prominent vasculature comprising medium- to large-sized, thick-walled vascular channels (brown arrows) in a hypercellular area (H&E, x100). (C) Note prominent vasculature comprising small- to medium-sized, thin-walled vascular channels (yellow arrows) in a hypocellular area (H&E, x100). (D) Note short fascicles of spindle cells with eosinophilic fusiform cytoplasm and slender, often vesicular, bland nuclei (green arrows), admixed with moderate infiltrates of lymphocytes and plasma cells (black arrows), occasional eosinophils (blue arrow), and fibrocollagenous stroma (H&E, x400). H&E: hematoxylin and eosin
Figure 2
Figure 2. IHC profile of inflammatory myofibroblastic tumor of the prostate gland
(A) Diffusely positive SMA stain: note intense and diffuse cytoplasmic staining (golden brown coloration) of lesional cells (SMA IHC, x400). (B) Negative CD34 stain: note lack of staining of lesional cells and intense membranous staining (golden brown discoloration) outlining vascular channels (CD34 IHC, x400). (C) Negative S100 stain: note lack of staining of lesional cells (S100 IHC, x400). IHC: immunohistochemistry; SMA: smooth muscle actin
See this image and copyright information in PMC

References

    1. Inflammatory myofibroblastic tumor. [ Mar; 2025 ]. 2024. https://www.pathologyoutlines.com/topic/softtissueinflammyofibro.html https://www.pathologyoutlines.com/topic/softtissueinflammyofibro.html
    1. Weiss SW, Goldblum JR, Folpe A. Enzinger and Weiss’s Soft Tissue Tumors. New York City (NY): Elsevier; 2007. Fibrous tumors of infancy and childhood; pp. 347–408.
    1. What do we know about inflammatory myofibroblastic tumors? - a systematic review. Siemion K, Reszec-Gielazyn J, Kisluk J, Roszkowiak L, Zak J, Korzynska A. Adv Med Sci. 2022;67:129–138. - PubMed
    1. Mesenchymal tumors of the prostate. McKenney JK. Mod Pathol. 2018;31:133–142. - PubMed
    1. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Lovly CM, Gupta A, Lipson D, et al. Cancer Discov. 2014;4:889–895. - PMC - PubMed

Publication types

LinkOut - more resources